BIOPROSPECT CHAIRMAN JUMPS BEFORE SOLAGRAN PUSHES HIM
November 29th 2008 02:11
Tuesday November 25, 2008
Daily news on ASX-listed biotechnology companies
* ASX, BIOTECHS UP: LIVING CELL UP 37%, CYTOPIA DOWN 9%
* BIOGUIDE: CLINUVEL – PHARMACEUTICAL TO COSMETIC … AND BACK
* CHINA DEAL TO BOOST POLARTECHNICS’ REVENUE 10-FOLD
* BIOPROSPECT CHAIRMAN JUMPS BEFORE SOLAGRAN PUSHES HIM
* STEM CELL REQUESTS FINANCIAL REVIEW TRADING HALT
* AVEXA AGM DISSENT ON REMUNERATION, ALL VOTES PASSED
* OPPOSITION TO COMPUMEDICS’ DIRECTOR ALAN ANDERSON
* LIM SEN YAP TAKES 14.7% OF ARANA
* OPTISCAN DIRECTOR KEITH DANIEL RETIRES
* GOODBYE BIOLAYER, HELLO ANTEO DIAGNOSTICS
To read all these articles in full, subscribe to Biotech Daily at the link above or at www.biotechdaily.com.au
BIOPROSPECT, SOLAGRAN
Bioprospect says that chairman Stephen Morrow and non-executive director Peter Landau resigned from the company yesterday.
Mr Morrow and Mr Landau said they were very pleased with the progress of the company in developing the natural termiticide, Termilone and early stage development of Solagran’s Bioeffectives range of products for use in the animal health sector.
Had Mr Morrow remained on the board, he would have faced a resolution proposed by 6.64 percent shareholder Solagran, that he be removed at tomorrow’s annual general meeting to be held in Melbourne (see Biotech Daily; October 24, 2008).
With the departure of Mr Morrow and Mr Landau, the company will be run by Solagran directors Charles Pellegrino and Peter Stedwell and Snr Sgt Anthony Langdon, who is under investigation by the Victoria Police.
Bioprospect fell 0.2 cents or 10.53 percent to 1.7 cents.
Solagran climbed three cents or 17.65 percent to 20 cents.
To read all these articles in full, subscribe to Biotech Daily at the link above or at www.biotechdaily.com.au
| 18 |
| Vote |
Add To: 
subscribe to this blog